Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Wachtel

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Psychopharmacology|January 1, 1982
Characteristic behavioural alterations in rats induced by rolipram and other selective adenosine cyclic 3', 5'-monophosphate phosphodiesterase inhibitorsH Wachtel
Journal of Neural Transmission|January 1, 1983
Species differences in behavioural effects of rolipram and other adenosine cyclic 3H, 5H-monophosphate phosphodiesterase inhibitorsH Wachtel
Pharmacopsychiatry|January 1, 1990
The second-messenger dysbalance hypothesis of affective disordersH Wachtel
Bioelectromagnetics|January 1, 1992
Bioelectric background fields and their implications for ELF dosimetryH Wachtel
Neuropharmacology|March 1, 1983
Potential antidepressant activity of rolipram and other selective cyclic adenosine 3',5'-monophosphate phosphodiesterase inhibitorsH Wachtel
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1991
Antiparkinsonian dopamine agonists: a review of the pharmacokinetics and neuropharmacology in animals and humansH Wachtel
Journal of Neural Transmission|January 1, 1989
Dysbalance of neuronal second messenger function in the aetiology of affective disorders: a pathophysiological concept hypothesising defects beyond first messenger receptorsH Wachtel
Biomedical Sciences Instrumentation|January 1, 1982
Microwave modulation of neural activityH Wachtel
Bioelectromagnetics|January 1, 1992
Methodological approaches to EMF microdosimetryH Wachtel
Clinical Neuropharmacology|January 1, 1992
Intraneuronal signalling systems as targets for the development of novel mood-stabilizing drugsH Wachtel
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Psychopharmacology|January 1, 1982
Characteristic behavioural alterations in rats induced by rolipram and other selective adenosine cyclic 3', 5'-monophosphate phosphodiesterase inhibitorsH Wachtel
Journal of Neural Transmission|January 1, 1983
Species differences in behavioural effects of rolipram and other adenosine cyclic 3H, 5H-monophosphate phosphodiesterase inhibitorsH Wachtel
Pharmacopsychiatry|January 1, 1990
The second-messenger dysbalance hypothesis of affective disordersH Wachtel
Bioelectromagnetics|January 1, 1992
Bioelectric background fields and their implications for ELF dosimetryH Wachtel
Neuropharmacology|March 1, 1983
Potential antidepressant activity of rolipram and other selective cyclic adenosine 3',5'-monophosphate phosphodiesterase inhibitorsH Wachtel
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1991
Antiparkinsonian dopamine agonists: a review of the pharmacokinetics and neuropharmacology in animals and humansH Wachtel
Journal of Neural Transmission|January 1, 1989
Dysbalance of neuronal second messenger function in the aetiology of affective disorders: a pathophysiological concept hypothesising defects beyond first messenger receptorsH Wachtel
Biomedical Sciences Instrumentation|January 1, 1982
Microwave modulation of neural activityH Wachtel
Bioelectromagnetics|January 1, 1992
Methodological approaches to EMF microdosimetryH Wachtel
Clinical Neuropharmacology|January 1, 1992
Intraneuronal signalling systems as targets for the development of novel mood-stabilizing drugsH Wachtel
Pageof 9